Cybrexa Therapeutics Announces First Patient Dosed with First-in-Class Peptide-Drug Conjugate CBX-12 in Phase 2 Trial in Ovarian Cancer
Rajit Manohar - Founder's Journey: Insights from Yale Engineering Innovators 10/28/2024 4:00PM—5:30PM
Letter From the Yale CBIT Director: Advancing Collaboration and Breakthroughs in Healthcare Innovation